What you should know:
1. TRC Capital Investment Corp., has turned its eye to AbbVie as the latest target of its mini-tender investment strategy. The firm has developed a reputation for its mini-tender investment strategy, where it attempts to secure a small minority ownership by buying stock for under-market value, according to an article on Seeking Alpha.
2. AbbVie released a statement recommending shareholders don’t sell to TRC.
3. AbbVie recommends shareholders obtain current share quotes, review terms and conditions, and consult with their stockbroker before taking any action.
More articles on ASCs:
The ‘new normal’ for ASCs: 16 admins on how the pandemic will change the field forever
Dr. Thomas Vikoren: Same-day TJR ‘made all the more important’ by COVID-19
Indiana orthopedic practice with surgery center to open
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
